| ...
For the past decade, 'hot new technologies' have promised to revolutionize
the drug discovery process, but these benefits have not materialized. Why
should we therefore believe thot the 'hot new technologies' of the present
will do any better? I guess whenever something new comes up, a new perspective
is gained and some people (usually those that do not understand the complexity
of the biology and of drug discovery) get totally hyped up. They just think
that this is a new way of doing things that will make everything easier, and
that if only we just follow these new paradigms, we will be hugely successful.
Anybody who has studied the history of drug discovery and other fields of
biology and medicine knows that breakthroughs do happen. The elucidation
of the human genome, for example, will certainly be classified as such a
breakthrough. However, breakthroughs not only make certain new things possible,
but also show where the limits are. Things have to be added to these breakthroughs
to make them really productive. The main mistake people made when genomics
came along was to say the following: we will know all the genes and will
have combinatorial chemistry, so let us play a 'big numbers' game with all
the potential targets (instead of validated targets) instead of trying to
understand everything. This approach was then expected to result in leads
and developmental compounds by purely empirical methods and thus to increase
productivity. That has not played out as expected. We have increased our
raw data numbers by orders of magnitude: numbers of a typical screening programme
for a large company have risen from ~250,000 data points per year in the
early 1990s to 60-100 million now. However, this has not led to a corresponding
increase in productivity because most hits are meaningless. I therefore think
people have now understood that you need a better understanding of things
first, which is why structural genomics, proteomics, X-ray crystallography
and molecular modelling are now coming to the fore. They are being used to
narrow the number of possibilities to really play this game in a more intellec-
tual and more thoughtful way. ... | Drug discovery
today 1st April 2001, Volume 6, No. 7 ISSN 1359-6446 www.drugdiscoverytoday.com |